Publications in collaboration with researchers from University Hospital of Zurich (3)

2022

  1. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme

    United European gastroenterology journal, Vol. 10, Núm. 3, pp. 330-343

  2. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 2, pp. 659-670

2020

  1. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

    Gastroenterology, Vol. 159, Núm. 5, pp. 1672-1685.e5